168 related articles for article (PubMed ID: 1894382)
1. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies.
Sato H; Sato Y; Ohishi I
Infect Immun; 1991 Oct; 59(10):3832-5. PubMed ID: 1894382
[TBL] [Abstract][Full Text] [Related]
2. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
3. Protective activities in mice of monoclonal antibodies against pertussis toxin.
Sato H; Sato Y
Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
[TBL] [Abstract][Full Text] [Related]
4. Effect of monoclonal antibody to pertussis toxin on toxin activity.
Sato H; Sato Y; Ito A; Ohishi I
Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody against pertussis toxin: relationship between toxin neutralization and mouse protection activities.
Sato H; Sato Y; Ito A
Ann Sclavo Collana Monogr; 1986; 3(1-2):259-67. PubMed ID: 2962594
[No Abstract] [Full Text] [Related]
6. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
Halperin SA; Issekutz TB; Kasina A
J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
Sato H; Ito A; Chiba J; Sato Y
Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antibodies elicited by immunization with pertussis toxin.
Kaslow HR; Schlotterbeck JD; Gotto J
Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
[TBL] [Abstract][Full Text] [Related]
9. Relationship between mouse-protecting and toxin-neutralizing activities of anti-pertussis toxin monoclonal antibodies.
Sato H; Sato Y; Ohishi I
Jpn J Med Sci Biol; 1990 Dec; 43(6):271-2. PubMed ID: 2101157
[No Abstract] [Full Text] [Related]
10. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.
Kenimer JG; Kim KJ; Probst PG; Manclark CR; Burstyn DG; Cowell JL
Hybridoma; 1989 Feb; 8(1):37-51. PubMed ID: 2466764
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.
Shahin RD; Witvliet MH; Manclark CR
Infect Immun; 1990 Dec; 58(12):4063-8. PubMed ID: 2254030
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against pertussis toxin. Biochemical characterization and biological activity.
Au-Jensen M; Schou C; Heron I
Ann Sclavo Collana Monogr; 1986; 3(1-2):269-76. PubMed ID: 2447922
[No Abstract] [Full Text] [Related]
15. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
Ibsen PH
Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
[TBL] [Abstract][Full Text] [Related]
16. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.
Nencioni L; Pizza M; Bugnoli M; De Magistris T; Di Tommaso A; Giovannoni F; Manetti R; Marsili I; Matteucci G; Nucci D
Infect Immun; 1990 May; 58(5):1308-15. PubMed ID: 2323818
[TBL] [Abstract][Full Text] [Related]
17. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis.
Olander RM; Muotiala A; Himanen JP; Karvonen M; Airaksinen U; Runeberg-Nyman K
Microb Pathog; 1991 Feb; 10(2):159-64. PubMed ID: 1909767
[TBL] [Abstract][Full Text] [Related]
19. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
Calver GA; Burton WW; Gardell CY
Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
[TBL] [Abstract][Full Text] [Related]
20. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
